摘要
The Middle East and North Africa(MENA) region has endured several major events of infection parenteral transmission. Recent work has established the utility of using hepatitis C virus(HCV) as a proxy biomarker for assessing the epidemic potential for human immunodeficiency virus(HIV) parenteral transmission. In this review, we use data on the prevalence of HCV infection antibody(seroprevalence) among general population and high risk population groups to assess the potential for HIV parenteral transmission in MENA. Relatively low prevalence of HCV infection in the general population groups was reported in most MENA countries indicating that parenteral HIV transmission at endemic levels does not appear to be a cause for concern. Nonetheless, there could be opportunities for localized HIV outbreaks and transmission of other blood-borne infections in some settings such as healthcare facilities. Though there have been steady improvements in safety measures related to parenteral modes of transmission in the region, these improvements have not been uniform across all countries. More precautions, including infection control training programs, surveillance systems for nosocomial infections and wider coverage and evaluation of hepatitis B virus immunization programs need to be implemented to avoid the unnecessary spread of HIV, HCV, and other blood-borne pathogens along the parenteral modes of transmission.
The Middle East and North Africa(MENA) region has endured several major events of infection parenteral transmission. Recent work has established the utility of using hepatitis C virus(HCV) as a proxy biomarker for assessing the epidemic potential for human immunodeficiency virus(HIV) parenteral transmission. In this review, we use data on the prevalence of HCV infection antibody(seroprevalence) among general population and high risk population groups to assess the potential for HIV parenteral transmission in MENA. Relatively low prevalence of HCV infection in the general population groups was reported in most MENA countries indicating that parenteral HIV transmission at endemic levels does not appear to be a cause for concern. Nonetheless, there could be opportunities for localized HIV outbreaks and transmission of other blood-borne infections in some settings such as healthcare facilities. Though there have been steady improvements in safety measures related to parenteral modes of transmission in the region, these improvements have not been uniform across all countries. More precautions, including infection control training programs, surveillance systems for nosocomial infections and wider coverage and evaluation of hepatitis B virus immunization programs need to be implemented to avoid the unnecessary spread of HIV, HCV, and other blood-borne pathogens along the parenteral modes of transmission.
引文
1 Frank C,Mohamed MK,Strickland GT,Lavanchy D,Arthur RR,Magder LS,El Khoby T,Abdel-Wahab Y,Aly Ohn ES,Anwar W,Sallam I.The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt.Lancet 2000;355:887-891[PMID:10752705 DOI:10.1016/S0140-6736(99)06527-7]
2 Hassan NF,el Ghorab NM,Abdel Rehim MS,el Sharkawy MS,el Sayed NM,Emara K,Soltant Y,Sanad M,Hibbs RG,Arthur RR.HIV infection in renal dialysis patients in Egypt.AIDS 1994;8:853[PMID:8086148 DOI:10.1097/00002030-199406000-00023]
3 El Sayed NM,Gomatos PJ,Beck-SaguéCM,Dietrich U,von Briesen H,Osmanov S,Esparza J,Arthur RR,Wahdan MH,Jarvis WR.Epidemic transmission of human immunodeficiency virus in renal dialysis centers in Egypt.J Infect Dis2000;181:91-97[PMID:10608755 DOI:10.1086/315167]
4 Visco-Comandini U,Cappiello G,Liuzzi G,Tozzi V,Anzidei G,Abbate I,Amendola A,Bordi L,Budabbus MA,Eljhawi OA,Mehabresh MI,Girardi E,Antinori A,Capobianchi MR,Snnerborg A,Ippolito G.Monophyletic HIV type 1 CRF02-AG in a nosocomial outbreak in Benghazi,Libya.AIDS Res Hum Retroviruses 2002;18:727-732[PMID:12167281 DOI:10.1089/088922202760072366]
5 de Oliveira T,Pybus OG,Rambaut A,Salemi M,Cassol S,Ciccozzi M,Rezza G,Gattinara GC,D’Arrigo R,Amicosante M,Perrin L,Colizzi V,Perno CF.Molecular epidemiology:HIV-1 and HCV sequences from Libyan outbreak.Nature2006;444:836-837[PMID:17171825 DOI:10.1038/444836a]
6 Yerly S,Quadri R,Negro F,Barbe KP,Cheseaux JJ,Burgisser P,Siegrist CA,Perrin L.Nosocomial outbreak of multiple bloodborne viral infections.J Infect Dis 2001;184:369-372[PMID:11443566 DOI:10.1086/322036]
7 Kane A,Lloyd J,Zaffran M,Simonsen L,Kane M.Transmission of hepatitis B,hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world:model-based regional estimates.Bull World Health Organ1999;77:801-807[PMID:10593027]
8 Simonsen L,Kane A,Lloyd J,Zaffran M,Kane M.Unsafe injections in the developing world and transmission of bloodborne pathogens:a review.Bull World Health Organ 1999;77:789 -800[PMID:10593026]
9 World Health Organization Regional Office for the Eastern Mediterranean.Progress report on HIV/AIDS:an update on‘3 by 5’.Jul 2005;Cairo,Egypt
10 Khawaja ZA,Gibney L,Ahmed AJ,Vermund SH.HIV/AIDS and its risk factors in Pakistan.AIDS 1997;11:843-848[PMID:9189208 DOI:10.1097/00002030-199707000-00002]
11 World Bank Group.World Bank Update 2005:HIV/AIDS in Pakistan.2005.Available from:URL:http://siteresources.worldbank.org/INTPAKISTAN/Resources/HIV-AIDSbrief-June2005-PK.pdf
12 World Bank.HIV/AIDS in Afghanistan.2006.Available from:URL:http://www.aidsdatahub.org/sites/default/files/documents/Afghanistan_2006_HIV_AIDS_brief_World_Bank.pdf.pdf
13 Joint United Nations Programme on HIV/AIDS.Country alignment and harmonization support to scaling up the HIV/AIDS response:the Somali experience.2006
14 World Health Organization Regional Office for the Eastern Mediterranean.Progress towards universal access to HIV prevention,treatment and care in the health sector:report on a baseline survey for the year 2005 in the World Health Organization Eastern Mediterranean Region.Draft 2006
15 Luby S,Khanani R,Zia M,Vellani Z,Ali M,Qureshi AH,Khan AJ,Abdul Mujeeb S,Shah SA,Fisher-Hoch S.Evaluation of blood bank practices in Karachi,Pakistan,and the government’s response.Health Policy Plan 2000;15:217-222[PMID:10837045 DOI:10.1093/heapol/15.2.217]
16 Zafar A,Aslam N,Nasir N,Meraj R,Mehraj V.Knowledge,attitudes and practices of health care workers regarding needle stick injuries at a tertiary care hospital in Pakistan.J Pak Med Assoc 2008;58:57-60[PMID:18333520]
17 Askarian M,Mirzaei K,McLaws ML.Attitudes,beliefs,and infection control practices of Iranian dentists associated with HIV-positive patients.Am J Infect Control 2006;34:530-533[PMID:17015160 DOI:10.1016/j.ajic.2006.03.006]
18 Askarian M,Mirzaei K,Cookson B.Knowledge,attitudes,and practice of iranian dentists with regard to HIV-related disease.Infect Control Hosp Epidemiol 2007;28:83-87[PMID:17230393 DOI:10.1086/509851]
19 Kabbash IA,El-Sayed NM,Al-Nawawy AN,Abou Salem Mel-S,El-Deek B,Hassan NM.Risk perception and precautions taken by health care workers for HIV infection in haemodialysis units in Egypt.East Mediterr Health J 2007;13:392 -407[PMID:17684860]
20 Khattab HA,Gineidy MA,Shorbagui N,Elnahal N.Report on a study of women living with HIV in Egypt.Egyptian Society for Population Studies and Reproductive Health 2007
21 Burans JP,McCarthy M,el Tayeb SM,el Tigani A,George J,Abu-Elyazeed R,Woody JN.Serosurvey of prevalence of human immunodeficiency virus amongst high risk groups in Port Sudan,Sudan.East Afr Med J 1990;67:650-655[PMID:2253574]
22 Hossini CH,Tripodi D,Rahhali AE,Bichara M,Betito D,Curtes JP,Verger C.[Knowledge and attitudes of health care professionals with respect to AIDS and the risk of occupational transmission of HIV in 2 Moroccan hospitals].Sante2000;10:315-321[PMID:11125337]
23 Yemen Ministry of Health.National Strategic Framework for the Control and Prevention of HIV/AIDS in the Republic of Yemen.2002.Available from:URL:http://hivaidsclearinghouse.unesco.org/search/format_long.phplang=en&ret=topics.php&fiche=6312
24 Kennedy M,O’Reilly D,Mah MW.The use of a qualityimprovement approach to reduce needlestick injuries in a Saudi Arabian hospital.Clin Perform Qual Health Care 1998;6:79 -83[PMID:10180126]
25 Hauri AM,Armstrong GL,Hutin YJ.The global burden of disease attributable to contaminated injections given in health care settings.Int J STD AIDS 2004;15:7-16[PMID:14769164 DOI:10.1258/095646204322637182]
26 Janjua NZ,Hutin YJ,Akhtar S,Ahmad K.Population beliefs about the efficacy of injections in Pakistan’s Sindh province.Public Health 2006;120:824-833[PMID:16876212 DOI:10 .1016/j.puhe.2006.05.004]
27 Altaf A,Fatmi Z,Ajmal A,Hussain T,Qahir H,Agboatwalla M.Determinants of therapeutic injection overuse among communities in Sindh,Pakistan.J Ayub Med Coll Abbottabad2004;16:35-38[PMID:15631369]
28 Mujeeb SA.Blood transfusion--a potential source of HIV/AIDS spread.J Pak Med Assoc 1993;43:1[PMID:8474211]
29 Ahmed SM.University Students.Situation Analysis-Behavioral Survey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
30 Ahmed SM.Truck Drivers.Situation Analysis-BehavioralSurvey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
31 Ahmed SM.Tea Sellers.Situation Analysis-Behavioral Survey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
32 Ahmed SM.TB Patients.Situation Analysis-Behavioral Survey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
33 Ahmed SM.Street Children.Situation Analysis-Behavioral Survey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
34 Ahmed SM.STDs.Situation Analysis-Behavioral Survey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
35 Ahmed SM.Sex Sellers.Situation Analysis-Behavioral Survey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
36 Ahmed SM.Military.Situation Analysis-Behavioral Survey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
37 Ahmed SM.Internally Displaced People.Situation AnalysisBehavioral Survey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
38 Ahmed SM.Antenatal.Situation Analysis-Behavioral Survey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
39 Ahmed SM.AIDS Patients.Situation Analysis-Behavioral Survey.Results&Discussions.Report.Sudan National AIDS Control Program.2004
40 Miller FD,Abu-Raddad LJ.Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt.Proc Natl Acad Sci USA 2010;107:14757-14762[PMID:20696911 DOI:1008877107]
41 Choo QL,Kuo G,Weiner AJ,Overby LR,Bradley DW,Houghton M.Isolation of a cDNA clone derived from a blood-borne non-A,non-B viral hepatitis genome.Science 1989;244:359-362[PMID:2523562 DOI:10.1126/science.2523562]
42 Alter MJ.Epidemiology of hepatitis C virus infection.World J Gastroenterol 2007;13:2436-2441[PMID:17552026 DOI:10 .3748/wjg.v19.i40.6703]
43 Colombo M,Rumi MG,Ninno ED.Treatment of chronic hepatitis C in Europe.J Hepatobiliary Pancreat Surg 2003;10:168 -171[PMID:14505151 DOI:10.1007/s00534-002-0728-4]
44 Rezvan H,Abolghassemi H,Kafiabad SA.Transfusiontransmitted infections among multitransfused patients in Iran:a review.Transfus Med 2007;17:425-433[PMID:18067646 DOI:10.1111/j.1365-3148.2007.00794.x]
45 Blower SM,Dowlatabadi H.Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission:An HIV Model,as an Example.Int Stat Rev 1994;62:229-243[DOI:10.2307/1403510]
46 Shepard CW,Finelli L,Alter MJ.Global epidemiology of hepatitis C virus infection.Lancet Infect Dis 2005;5:558-567[PMID:16122679 DOI:10.1016/S1473-3099(05)70216-4]
47 Baggaley RF,Boily MC,White RG,Alary M.Risk of HIV-1transmission for parenteral exposure and blood transfusion:a systematic review and meta-analysis.AIDS 2006;20:805 -812[PMID:16549963 DOI:10.1097/01.aids.0000218543.46963.6d]
48 Boily MC,Pickles M,Vickerman P,Buzdugan R,Isac S,Deering KN,Blanchard JF,Moses S,Lowndes CM,Ramesh BM,Demers E,Alary M.Using mathematical modelling to investigate the plausibility of attributing observed antenatal clinic declines to a female sex worker intervention in Karnataka state,India.AIDS 2008;22 Suppl 5:S149-S164[PMID:19098475 DOI:10.1097/01.aids.0000343773.59776.5b]
49 Goldmann DA.Blood-borne pathogens and nosocomial infections.J Allergy Clin Immunol 2002;110:S21-S26[PMID:12170239 DOI:10.1067/mai.2002.125337]
50 Walker PR,Worobey M,Rambaut A,Holmes EC,Pybus OG.Epidemiology:Sexual transmission of HIV in Africa.Nature2003;422:679[PMID:12700750 DOI:10.1038/422679a]
51 Schmid GP,BuvéA,Mugyenyi P,Garnett GP,Hayes RJ,Williams BG,Calleja JG,De Cock KM,Whitworth JA,Kapiga SH,Ghys PD,Hankins C,Zaba B,Heimer R,Boerma JT.Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections.Lancet 2004;363:482-488[PMID:14962531 DOI:10.1016/S0140-6736(04)15497-4]
52 Vickerman P,Hickman M,May M,Kretzschmar M,Wiessing L.Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug usersAn ecological analysis.Addiction 2010;105:311-318[PMID:19922515 DOI:10.1111/j.1360-0443.2009.02759.x]
53 Vickerman P,Martin NK,Hickman M.Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings--implications for intervention impact.Drug Alcohol Depend 2012;123:122-131[PMID:22138540 DOI:10.1016/j.drugalcdep.2011.10.032]
54 Vickerman P,Martin NK,Roy A,Beattie T,Jarlais DD,Strathdee S,Wiessing L,Hickman M.Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmissionDrug Alcohol Depend 2013;132:172-181[PMID:23453261DOI:10.1016/j.drugalcdep.2013.01.020]
55 Maayan S,Shufman EN,Engelhard D,Shouval D.Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem.Addiction 1994;89:869-874[PMID:8081185 DOI:10.1111/j.1360-0443.1994.tb00990.x]
56 Mumtaz G,Hilmi N,McFarland W,Kaplan RL,Akala FA,Semini I,Riedner G,Tawil O,Wilson D,Abu-Raddad LJ.Are HIV epidemics among men who have sex with men emerging in the Middle East and North Africa:a systematic review and data synthesis.PLoS Med 2010;8:e1000444[PMID:21829329 DOI:10.1371/journal.pmed.1000444]
57 Mumtaz G,Hilmi N,Akala FA,Semini I,Riedner G,Wilson D,Abu-Raddad LJ.HIV-1 molecular epidemiology evidence and transmission patterns in the Middle East and North Africa.Sex Transm Infect 2011;87:101-106[PMID:21036790DOI:10.1136/sti.2010.043711]
58 Abu-Raddad LJ,Hilmi N,Mumtaz G,Benkirane M,Akala FA,Riedner G,Tawil O,Wilson D.Epidemiology of HIV infection in the Middle East and North Africa.AIDS 2010;24Suppl 2:S5-23[PMID:20610949 DOI:10.1097/01.aids.0000386729.56683.33]
59 Abu-Raddad L,Akala FA,Semini I,Riedner G,Wilson D,Tawil O.Characterizing the HIV/AIDS epidemic in the Middle East and North Africa:Time for Strategic Action.Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project.World Bank/UNAIDS/WHO Publication.Washington DC:The World Bank Press,2010[DOI:10.1596/978-0-8213-8137-3]
60 Sy T,Jamal MM.Epidemiology of hepatitis C virus(HCV)infection.Int J Med Sci 2006;3:41-46[PMID:16614741 DOI:10 .7150/ijms.3.41]
61 Lavanchy D.Evolving epidemiology of hepatitis C virus.Clin Microbiol Infect 2011;17:107-115[PMID:21091831 DOI:10 .1111/j.1469-0691.2010.03432.x]
62 El-Zanaty F,Way A.Egypt Demographic and Health Survey2008.Egyptian:Ministry of Health.Cairo:El-Zanaty and Associates,and Macro International,2009.Available from:URL:https://www.measuredhs.com/pubs/pdf/FR220/FR220.pdf
63 Mohamoud YA,Mumtaz GR,Riome S,Miller D,AbuRaddad LJ.The epidemiology of hepatitis C virus in Egypt:a systematic review and data synthesis.BMC Infect Dis 2013;13 :288[PMID:23799878 DOI:10.1186/1471-2334-13-288]
64 Umar M,Bushra HT,Ahmad M,Data A,Ahmad M,Khurram M,Usman S,Arif M,Adam T,Minhas Z,Arif A,Naeem A,Ejaz K,Butt Z,Bilal M.Hepatitis C in Pakistan:a re-view of available data.Hepat Mon 2010;10:205-214[PMID:22308140]
65 Raja NS,Janjua KA.Epidemiology of hepatitis C virus infection in Pakistan.J Microbiol Immunol Infect 2008;41:4-8[PMID:18327420]
66 Khokhar N,Gill ML,Malik GJ.General seroprevalence of hepatitis C and hepatitis B virus infections in population.J Coll Physicians Surg Pak 2004;14:534-536[PMID:15353136]
67 Aslam M,Aslam J,Mitchell BD,Munir KM.Association between smallpox vaccination and hepatitis C antibody positive serology in Pakistani volunteers.J Clin Gastroenterol 2005;39:243-246[PMID:15718868 DOI:10.1097/01.mcg.0000153286.02694.14]
68 Strickland GT.Liver disease in Egypt:hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors.Hepatology 2006;43:915-922[PMID:16628669 DOI:10 .1002/hep.21173]
69 Idrees M,Riazuddin S.Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission.BMC Infect Dis2008;8:69[PMID:18498666 DOI:10.1186/1471-2334-8-69]
70 Bakir TM,Kurbaan KM,al Fawaz I,Ramia S.Infection with hepatitis viruses(B and C)and human retroviruses(HTLV-1and HIV)in Saudi children receiving cycled cancer chemotherapy.J Trop Pediatr 1995;41:206-209[PMID:7563271 DOI:10 .1093/tropej/41.4.206]
71 al-Faleh FZ,Ayoola EA,al-Jeffry M,al-Rashed R,al-Mofarreh M,Arif M,Ramia S,al-Karawi M,al-Shabrawy M.Prevalence of antibody to hepatitis C virus among Saudi Arabian children:a community-based study.Hepatology 1991;14:215 -218[PMID:1650324 DOI:10.1002/hep.1840140202]
72 Shobokshi OA,Serebour FE,Al-Drees AZ,Mitwalli AH,Qahtani A,Skakni LI.Hepatitis C virus seroprevalence rate among Saudis.Saudi Med J 2003;24 Suppl 2:S81-S86[PMID:12897907]
73 Aceti A,Taliani G,Bruni R,Sharif OS,Moallin KA,Celestino D,Quaranta G,Sebastiani A.Hepatitis C virus infection in chronic liver disease in Somalia.Am J Trop Med Hyg 1993;48:581 -584[PMID:7683179]
74 Bile K,Mohamud O,Aden C,Isse A,Norder H,Nilsson L,Magnius L.The risk for hepatitis A,B,and C at two institutions for children in Somalia with different socioeconomic conditions.Am J Trop Med Hyg 1992;47:357-364[PMID:1524149]
75 Butt T,Amin MS.Seroprevalence of hepatitis B and C infections among young adult males in Pakistan.East Mediterr Health J 2008;14:791-797[PMID:19166161]
76 Ali SA,Donahue RM,Qureshi H,Vermund SH.Hepatitis B and hepatitis C in Pakistan:prevalence and risk factors.Int J Infect Dis 2009;13:9-19[PMID:18835208 DOI:10.1016/j.ijid.2008.06.019]
77 Mohamed MK,Abdel-Hamid M,Mikhail NN,Abdel-Aziz F,Medhat A,Magder LS,Fix AD,Strickland GT.Intrafamilial transmission of hepatitis C in Egypt.Hepatology 2005;42:683 -687[PMID:16032698 DOI:10.1002/hep.20811]
78 Plancoulaine S,Mohamed MK,Arafa N,Bakr I,Rekacewicz C,Trégout DA,Obach D,El Daly M,Thiers V,Féray C,Abdel-Hamid M,Abel L,Fontanet A.Dissection of familial correlations in hepatitis C virus(HCV)seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection.Gut 2008;57:1268-1274[PMID:18480169DOI:10.1136/gut.2007.140681]
79 Morad WS.Transmission of hepatitis C between spouses an epidemiological study at National Liver Institute hospital.Int J Infect Dis 2011;15:S81
80 Shebl FM,El-Kamary SS,Saleh DA,Abdel-Hamid M,Mikhail N,Allam A,El-Arabi H,Elhenawy I,El-Kafrawy S,El-Daly M,Selim S,El-Wahab AA,Mostafa M,Sharaf S,Hashem M,Heyward S,Stine OC,Magder LS,Stoszek S,Strickland GT.Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian vil-lages.J Med Virol 2009;81:1024-1031[PMID:19382251 DOI:10 .1002/jmv.21480]
81 El-Zayadi A,Khalifa AA,El-Misiery A,Naser AM,Dabbous H,Aboul-Ezz AA.Evaluation of risk factors for intrafamilial transmission of HCV infection in Egypt.J Egypt Public Health Assoc 1997;72:33-51[PMID:17265624]
82 Kandil ME,Rasheed MA,Saad NE.Hepatitis C and B viruses among some high risk groups of Egyptian children.J Med Sci 2007;7:1259-1267
83 Hammad AM,Zaghloul MH.Hepatitis G virus infection in Egyptian children with chronic renal failure(single centre study).Ann Clin Microbiol Antimicrob 2009;8:36[PMID:20015406 DOI:10.1186/1476-0711-8-36]
84 el-Nanawy AA,el Azzouni OF,Soliman AT,Amer AE,Demian RS,el-Sayed HM.Prevalence of hepatitis-C antibody seropositivity in healthy Egyptian children and four high risk groups.J Trop Pediatr 1995;41:341-343[PMID:8606441DOI:10.1093/tropej/41.6.341]
85 El-Karaksy H,Anwar GH,El-Raziky MS,El-Hawary M,Hashem M,El-Sayed R,El-Shabrawi M,Mohsen N,Fouad H,Esmat G.Anti-HCV prevalence among diabetic and nondiabetic Egyptian children.Curr Diabetes Rev 2010;6:388-392[PMID:20879976 DOI:10.2174/157339910793499137]
86 Saidane N,Saidi M,Derdous C,Rouabhia S,Soltani F,Ouarhlent Y.Various complications in haemophiliacs managed by Hospital University of Batna,Algeria.J Thromb Haemost2011;9:923
87 Ben Othman S,Bouzgarrou N,Achour A,Bourlet T,Pozzetto B,Trabelsi A.[High prevalence and incidence of hepatitis C virus infections among dialysis patients in the EastCentre of Tunisia].Pathol Biol(Paris)2004;52:323-327[PMID:15261374 DOI:10.1016/j.patbio.2003.07.001]
88 Sekkat S,Kamal N,Benali B,Fellah H,Amazian K,Bourquia A,El Kholti A,Benslimane A.[Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco].Nephrol Ther 2008;4:105-110[PMID:18272446 DOI:10.1016/j.nephro.2007.11.007]
89 Saleh DA,Shebl F,Abdel-Hamid M,Narooz S,Mikhail N,El-Batanony M,El-Kafrawy S,El-Daly M,Sharaf S,Hashem M,El-Kamary S,Magder LS,Stoszek SK,Strickland GT.Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt.Trans R Soc Trop Med Hyg 2008;102:921 -928[PMID:18514243 DOI:10.1016/j.trstmh.2008.04.011]
90 Arafa N,El Hoseiny M,Rekacewicz C,Bakr I,El-Kafrawy S,El Daly M,Aoun S,Marzouk D,Mohamed MK,Fontanet A.Changing pattern of hepatitis C virus spread in rural areas of Egypt.J Hepatol 2005;43:418-424[PMID:16019104 DOI:10 .1016/j.jhep.2005.03.021]
91 el-Sadawy M,Ragab H,el-Toukhy H,el-Mor Ael-L,Mangoud AM,Eissa MH,Afefy AF,el-Shorbagy E,Ibrahem IA,Mahrous S,Abdel-Monem A,Sabee EI,Ismail A,Morsy TA,Etewa S,Nor Edin E,Mostafa Y,Abouel-Magd Y,Hassan MI,Lakouz K,Abdel-Aziz K,el-Hady G,Saber M.Hepatitis C virus infection at Sharkia Governorate,Egypt:seroprevalence and associated risk factors.J Egypt Soc Parasitol 2004;34 :367-384[PMID:15124747]
92 Habib M,Mohamed MK,Abdel-Aziz F,Magder LS,AbdelHamid M,Gamil F,Madkour S,Mikhail NN,Anwar W,Strickland GT,Fix AD,Sallam I.Hepatitis C virus infection in a community in the Nile Delta:risk factors for seropositivity.Hepatology 2001;33:248-253[PMID:11124843 DOI:10 .1053/jhep.2001.20797]
93 Kalil KA,Farghally HS,Hassanein KM,Abd-Elsayed AA,Hassanein FE.Hepatitis C virus infection among paediatric patients attending University of Assiut Hospital,Egypt.East Mediterr Health J 2010;16:356-361[PMID:20795415]
94 Barakat SH,El-Bashir N.Hepatitis C virus infection among healthy Egyptian children:prevalence and risk factors.J Viral Hepat 2011;18:779-784[PMID:21992795 DOI:10.1111/j.1365-2893.2010.01381.x]
95 Mohamed MK,Hussein MH,Massoud AA,Rakhaa MM,Shoeir S,Aoun AA,Aboul Naser M.Study of the risk factors for viral hepatitis C infection among Egyptians applying for work abroad.J Egypt Public Health Assoc 1996;71:113-147[PMID:17217004]
96 Cacoub P,Ohayon V,Sekkat S,Dumont B,Sbai A,Lunel F,Benslimane A,Godeau P,Archane MI.[Epidemiologic and virologic study of hepatitis C virus infections in Morocco].Gastroenterol Clin Biol 2000;24:169-173[PMID:12687957]
97 Kutrani H,El-Gatit A,Shekhteryea A,El-Gitait Y,Sudani O,Akoub S.[Demographic factors influencing hepatitis B and C infection in Benghazi,Libyan Arab Jamahiriya].East Mediterr Health J 2007;13:85-97[PMID:17546910]
98 Laraqui O,Laraqui S,Tripodi D,Zahraoui M,Caubet A,Verger C,Laraqui CH.[Assessing knowledge,attitude,and practice on occupational blood exposure in caregiving facilities,in Morocco].Med Mal Infect 2008;38:658-666[PMID:18954949 DOI:10.1016/j.medmal.2008.09.009]
99 Zahraoui-Mehadji M,Baakrim MZ,Laraqui S,Laraqui O,El Kabouss Y,Verger C,Caubet A,Laraqui CH.[Infectious risks associated with blood exposure for traditional barbers and their customers in Morocco].Sante 2004;14:211-216[PMID:15745870]
100 Candan F,AlagzlüH,Poyraz O,Sümer H.Prevalence of hepatitis B and C virus infection in barbers in the Sivas region of Turkey.Occup Med(Lond)2002;52:31-34[PMID:11872792 DOI:10.1093/occmed/52.1.31]
101 Khattak MN,Akhtar S,Mahmud S,Roshan TM.Factors influencing Hepatitis C virus sero-prevalence among blood donors in north west Pakistan.J Public Health Policy 2008;29:207 -225[PMID:18523475 DOI:10.1057/jphp.2008.7]
102 Janjua NZ,Nizamy MA.Knowledge and practices of barbers about hepatitis B and C transmission in Rawalpindi and Islamabad.J Pak Med Assoc 2004;54:116-119[PMID:15129868]
103 Quinti I,Renganathan E,El Ghazzawi E,Divizia M,Sawaf G,Awad S,Pana A,Rocchi G.Seroprevalence of HIV and HCV infections in Alexandria,Egypt.Zentralbl Bakteriol 1995;283:239-244[PMID:8825115 DOI:10.1016/S0934-8840(11)80205-7]
104 Mohammad Alizadeh AH,Alavian SM,Jafari K,Yazdi N.Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.World J Gastroenterol 2005;11:4085-4089[PMID:15996035]
105 Nassirimanesh B.Proceedings abstract for the fourth national harm reduction conference.Harm Reduction Coalition;2002;Seattle,USA
106 Ansari JA,Salman M,Safdar RM,Ikram N,Mahmood T,Zaheer HA,Walke H,Asghar RJ.HIV/AIDS outbreak investigation in Jalalpur Jattan(JPJ),Gujrat,Pakistan.J Epidemiol Glob Health 2013;3:261-268[PMID:24206797 DOI:10.1016/j.jegh.2013.06.001]
107 Ramia S,Eid-Fares J.Distribution of hepatitis C virus genotypes in the Middle East.Int J Infect Dis 2006;10:272-277[PMID:16564719 DOI:10.1016/j.ijid.2005.07.008]
108 Talaat M,Kandeel A,Rasslan O,Hajjeh R,Hallaj Z,El-Sayed N,Mahoney FJ.Evolution of infection control in Egypt:achievements and challenges.Am J Infect Control 2006;34:193 -200[PMID:16679176 DOI:10.1016/j.ajic.2005.05.028]
109 Al-Ghamdi S,Gedebou M,Bilal NE.Nosocomial infections and misuse of antibiotics in a provincial community hospital,Saudi Arabia.J Hosp Infect 2002;50:115-121[PMID:11846538DOI:10.1053/jhin.2001.1149]
110 UNAIDS RST MENA.Notes on AIDS in the Middle East and North Africa.2008.Available from:URL:http://www.worldbank.org/en/region/mena
111 Jurjus AR,Kahhaleh J;National AIDS Program,World Health Organization Regional Office for the Eastern Mediterranean.Knowledge,Attitudes,Beliefs,and Practices of the Lebanese Concerning HIV/AIDS.2004;Beirut,Lebanon
112 Joint United Nations Programme on HIV/AIDS Regional Support Team for the Middle East and North Africa.KeyFindings on HIV Status in the West Bank and Gaza.Working Document 2007
113 Mirmomen S,Alavian SM,Hajarizadeh B,Kafaee J,Yektaparast B,Zahedi MJ,Zand V,Azami AA,Hosseini MM,Faridi AR,Davari K,Hajibeigi B.Epidemiology of hepatitis B,hepatitis C,and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran:a multicenter study.Arch Iran Med 2006;9:319-323[PMID:17061602]
114 Taziki O,Espahbodi F.Prevalence of hepatitis C virus infection in hemodialysis patients.Saudi J Kidney Dis Transpl 2008;19 :475-478[PMID:18445917]
115 Alavian SM,Bagheri-Lankarani K,Mahdavi-Mazdeh M,Nourozi S.Hepatitis B and C in dialysis units in Iran:changing the epidemiology.Hemodial Int 2008;12:378-382[PMID:18638096 DOI:10.1111/j.1542-4758.2008.00284.x]
116 Kocak N,Hepgul S,Ozbayburtlu S,Altunay H,Ozsoy MF,Kosan E,Aksu Y,Yilmaz G,Pahsa A.Trends in major transfusion-transmissible infections among blood donors over17 years in Istanbul,Turkey.J Int Med Res 2006;32:671-675[PMID:15587762 DOI:10.1177/147323000403200613]
117 El-Zanaty F,Way A.Egypt Demographic and Health Survey 2005.Cairo,Egypt:Ministry of Health and Population,National Population Council,El-Zanaty and Associates,and ORC Macro,2006
118 Mujeeb SA,Pearce MS.Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh,Pakistan.BMC Infect Dis 2008;8:43[PMID:18402660 DOI:1471-2334-8-43]
119 Mohamed MK,Magder LS,Abdel-Hamid M,El-Daly M,Mikhail NN,Abdel-Aziz F,Medhat A,Thiers V,Strickland GT.Transmission of hepatitis C virus between parents and children.Am J Trop Med Hyg 2006;75:16-20[PMID:16837701]
120 Magder LS,Fix AD,Mikhail NN,Mohamed MK,Abdel-Hamid M,Abdel-Aziz F,Medhat A,Strickland GT.Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data.Int J Epidemiol 2005;34:160 -165[PMID:15647312 DOI:10.1093/ije/dyh370]
121 Abbas Z,Jeswani NL,Kakepoto GN,Islam M,Mehdi K,Jafri W.Prevalence and mode of spread of hepatitis B and C in rural Sindh,Pakistan.Trop Gastroenterol 2008;29:210-216[PMID:19323090]
122 Memish ZA.Infection control in Saudi Arabia:meeting the challenge.Am J Infect Control 2002;30:57-65[PMID:11852419DOI:10.1067/mic.2002.120905]
123 Dupire B,Abawi AK,Ganteaume C,Lam T,Truze P,Martet G.[Establishment of a blood transfusion center at Kabul(Afghanistan)].Sante 1999;9:18-22[PMID:10210798]
124 Ministry of Public Health.Central Blood Bank report of testing blood donors from March-December.2006;Kabul,Afghanistan
125 Todd CS,Ahmadzai M,Atiqzai F,Miller S,Smith JM,Ghazanfar SA,Strathdee SA.Seroprevalence and correlates of HIV,syphilis,and hepatitis B and C virus among intrapartum patients in Kabul,Afghanistan.BMC Infect Dis 2008;8:119 [PMID:18798996 DOI:10.1186/1471-2334-8-119]
126 Ayed Z,Houinato D,Hocine M,Ranger-Rogez S,Denis F.[Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria].Bull Soc Pathol Exot1995;88:225-228[PMID:8646011]
127 Aidaoui M,Bouzbid S,Laouar M.[Seroprevalence of HIV infection in pregnant women in the Annaba region(Algeria)].Rev Epidemiol Sante Publique 2008;56:261-266[PMID:18687541 DOI:10.1016/j.respe.2008.05.023]
128 Almawi WY,Qadi AA,Tamim H,Ameen G,Bu-Ali A,Arrayid S,Abou Jaoude MM.Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.Transplant Proc 2004;36:1824-1826[PMID:15350487 DOI:10.1016/j.transproceed.2004.07.019]
129 Dray X,Dray-Spira R,Bronstein JA,Mattera D.[Prevalences of HIV,hepatitis B and hepatitis C in blood donors in the Republic of Djibouti].Med Trop(Mars)2005;65:39-42[PMID:15903075]
130 Abdel-Wahab MF,Zakaria S,Kamel M,Abdel-Khaliq MK,Mabrouk MA,Salama H,Esmat G,Thomas DL,Strickland GT.High seroprevalence of hepatitis C infection among risk groups in Egypt.Am J Trop Med Hyg 1994;51:563-567[PMID:7527186]
131 El-Gilany AH,El-Fedawy S.Bloodborne infections among student voluntary blood donors in Mansoura University,Egypt.East Mediterr Health J 2006;12:742-748[PMID:17333818]
132 Wasfi OA,Sadek NA.Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria,Egypt.East Mediterr Health J 2011;17:238-242[PMID:21735965]
133 Farawela H,Khorshied M,Shaheen I,Gouda H,Nasef A,Abulata N,Mahmoud HA,Zawam HM,Mousa SM.The association between hepatitis C virus infection,genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin’s lymphoma risk in Egypt.Infect Genet Evol 2012;12:1189-1194[PMID:22522002 DOI:10.1016/j.meegid.2012.04.007]
134 Khattab MA,Eslam M,Sharwae MA,Hamdy L.Seroprevalence of hepatitis C and B among blood donors in Egypt:Minya Governorate,2000-2008.Am J Infect Control 2010;38:640 -641[PMID:20400204 DOI:10.1016/j.ajic.2009.12.016]
135 Tanaka Y,Agha S,Saudy N,Kurbanov F,Orito E,Kato T,Abo-Zeid M,Khalaf M,Miyakawa Y,Mizokami M.Exponential spread of hepatitis C virus genotype 4a in Egypt.J Mol Evol 2004;58:191-195[PMID:15042339 DOI:10.1007/s00239-003-2541-3]
136 Darwish MA,Raouf TA,Rushdy P,Constantine NT,Rao MR,Edelman R.Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors.Am J Trop Med Hyg 1993;49:440-447[PMID:7692754]
137 el Gohary A,Hassan A,Nooman Z,Lavanchy D,Mayerat C,el Ayat A,Fawaz N,Gobran F,Ahmed M,Kawano F.High prevalence of hepatitis C virus among urban and rural population groups in Egypt.Acta Trop 1995;59:155-161[PMID:7545863 DOI:10.1016/0001-706X(95)00075-P]
138 Awadalla HI,Ragab MH,Nassar NA,Osman MA.Risk factors of hepatitis C infection among Egyptian blood donors.Cent Eur J Public Health 2011;19:217-221[PMID:22432397]
139 Arthur RR,Hassan NF,Abdallah MY,el-Sharkawy MS,Saad MD,Hackbart BG,Imam IZ.Hepatitis C antibody prevalence in blood donors in different governorates in Egypt.Trans R Soc Trop Med Hyg 1997;91:271-274[PMID:9231192 DOI:10.1016/S0035-9203(97)90070-5]
140 Bassily S,Hyams KC,Fouad RA,Samaan MD,Hibbs RG.A high risk of hepatitis C infection among Egyptian blood donors:the role of parenteral drug abuse.Am J Trop Med Hyg1995;52:503-505[PMID:7541968]
141 El-Raziky MS,El-Hawary M,Esmat G,Abouzied AM,ElKoofy N,Mohsen N,Mansour S,Shaheen A,Abdel Hamid M,El-Karaksy H.Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children.World J Gastroenterol 2007;13:1828-1832[PMID:17465475]
142 El Sherbini A,Mohsen SA,Hasan W,Mostafa S,El Gohary K,Moneib A,Abaza AH.The peak impact of an Egyptain outbreak of hepatitis C virus:has it passed or has not yet occurredLiver Int 2007;27:876-877[PMID:17617132 DOI:10 .1111/j.1478-3231.2007.01501.x]
143 Madwar MA,El-Gindy I,Fahmy HM,Shoeb NM,Massoud BA.Hepatitis C virus transmission in family members of Egyptian patients with HCV related chronic liver disease.J Egypt Public Health Assoc 1999;74:313-332[PMID:17219873]
144 Shemer-Avni Y,el Astal Z,Kemper O,el Najjar KJ,Yaari A,Hanuka N,Margalith M,Sikuler E.Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip.J Med Virol 1998;56:230-233[PMID:9783690 DOI:10.1002/(SI CI)1096-9071(199811)56]
145 el-Ghazzawi E,Drew L,Hamdy L,El-Sherbini E,SadekSel-D,Saleh E.Intravenous drug addicts:a high risk group for infection with human immunodeficiency virus,hepatitis viruses,cytomegalo virus and bacterial infections in Alexandria Egypt.J Egypt Public Health Assoc 1995;70:127-150[PMID:17214204]
146 Salama KM,Selim Oel-S.Hepatitis G virus infection in multitransfused Egyptian children.Pediatr Hematol Oncol 2009;26 :232-239[PMID:19437325 DOI:10.1080/08880010902897591]
147 Lehman EM,Wilson ML.Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt:a systematic review and meta-analysis.Int J Cancer2009;124:690-697[PMID:18973270 DOI:10.1002/ijc.23937]
148 Kumar RM,Frossad PM,Hughes PF.Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women.Eur J Obstet Gynecol Reprod Biol 1997;75:177-182[PMID:9447371 DOI:10.1016/S0301-2115(97)00130-9]
149 Hassan MM,Zaghloul AS,El-Serag HB,Soliman O,Patt YZ,Chappell CL,Beasley RP,Hwang LY.The role of hepatitis C in hepatocellular carcinoma:a case control study among Egyptian patients.J Clin Gastroenterol 2001;33:123-126[PMID:11468438 DOI:10.1097/00004836-200108000-00006]
150 Strickland GT,Elhefni H,Salman T,Waked I,Abdel-Hamid M,Mikhail NN,Esmat G,Fix A.Role of hepatitis C infection in chronic liver disease in Egypt.Am J Trop Med Hyg 2002;67 :436-442[PMID:12452500]
151 Hassan NF,Kotkat A.Prevalence of antibodies to hepatitis C virus in pregnant women in Egypt.J Infect Dis 1993;168:248 -249[PMID:8390542 DOI:10.1093/infdis/168.1.248]
152 Zahran KM,Badary MS,Agban MN,Abdel Aziz NH.Pattern of hepatitis virus infection among pregnant women and their newborns at the Women’s Health Center of Assiut University,Upper Egypt.Int J Gynaecol Obstet 2010;111:171-174[PMID:20708181 DOI:10.1016/j.ijgo.2010.06.013]
153 Abo Elmagd EK,Abdel-Wahab KS,Alrasheedy ZE,Khalifa AS.An Egyptian study of mother to child transmission of hepatitis C virus.Int J Virol 2011;7:100-108
154 Kassem AS,el-Nawawy AA,Massoud MN,el-Nazar SY,Sobhi EM.Prevalence of hepatitis C virus(HCV)infection and its vertical transmission in Egyptian pregnant women and their newborns.J Trop Pediatr 2000;46:231-233[PMID:10996985 DOI:10.1093/tropej/46.4.231]
155 Nafeh MA,Medhat A,Shehata M,Mikhail NN,Swifee Y,Abdel-Hamid M,Watts S,Fix AD,Strickland GT,Anwar W,Sallam I.Hepatitis C in a community in Upper Egypt:I.Cross-sectional survey.Am J Trop Med Hyg 2000;63:236-241[PMID:11421370]
156 Abdel-Aziz F,Habib M,Mohamed MK,Abdel-Hamid M,Gamil F,Madkour S,Mikhail NN,Thomas D,Fix AD,Strickland GT,Anwar W,Sallam I.Hepatitis C virus(HCV)infection in a community in the Nile Delta:population description and HCV prevalence.Hepatology 2000;32:111-115[PMID:10869297 DOI:10.1053/jhep.2000.8438]
157 Aguilar CE,Soliman AS,McConnell DS,Zekri AR,Banerjee M,Omar A,Sharawy M,Omar S,Raouf A,Sowers MR.Androgen profiles among Egyptian adults considering liver status.J Gastroenterol Hepatol 2008;23:e137-e145[PMID:17524040 DOI:10.1111/j.1440-1746.2007.04949.x]
158 Darwish MA,Faris R,Darwish N,Shouman A,Gadallah M,El-Sharkawy MS,Edelman R,Grumbach K,Rao MR,Clemens JD.Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt:a community-based study.Am J Trop Med Hyg 2001;64:147-153[PMID:11442209]
159 el-Sayed NM,Gomatos PJ,Rodier GR,Wierzba TF,Darwish A,Khashaba S,Arthur RR.Seroprevalence survey of Egyptian tourism workers for hepatitis B virus,hepatitis C virus,human immunodeficiency virus,and Treponema pallidum infections:association of hepatitis C virus infections with specific regions of Egypt.Am J Trop Med Hyg 1996;55:179 -184[PMID:8780457]
160 Ansar MM,Kooloobandi A.Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht.J Viral Hepat 2002;9:390-392[PMID:12225335DOI:10.1046/j.1365-2893.2002.00368.x]
161 Karimi M,Ghavanini AA.Seroprevalence of HBsAg,antiHCV,and anti-HIV among haemophiliac patients in Shiraz Iran.Haematologia(Budap)2001;31:251-255[PMID:11855788DOI:10.1163/15685590152763809]
162 Ghavanini AA,Sabri MR.Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran.East Mediterr Health J 2000;6:1114-1116[PMID:12197336]
163 Rezvan H,Ahmadi J,Farhadi M,Taroyan S.A preliminary study on the prevalence of anti-HCV amongst healthy blood donors in Iran.Vox Sang 1994;67:100
164 Rahbar AR,Rooholamini S,Khoshnood K.Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users(IDUs)in Mashhad,Iran.Int J Drug Policy 2004;15:151-155[DOI10 .1016/j.drugpo.2003.07.001]
165 Pourshams A,Malekzadeh R,Monavvari A,Akbari MR,Mohamadkhani A,Yarahmadi S,Seddighi N,Mohamadnejad M,Sotoudeh M,Madjlessi A.Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors.J Gastroenterol Hepatol 2005;20:229-233[PMID:15683425 DOI:10.1111/j.1440-1746.2004.03511.x]
166 Khedmat H,Fallahian F,Abolghasemi H,Alavian SM,Hajibeigi B,Miri SM,Jafari AM.Seroepidemiologic study of hepatitis B virus,hepatitis C virus,human immunodeficiency virus and syphilis infections in Iranian blood donors.Pak J Biol Sci 2007;10:4461-4466[PMID:19093512 DOI:10.3923/pjbs.2007.4461.4466]
167 Vahdani P,Hosseini-Moghaddam SM,Gachkar L,Sharafi K Prevalence of hepatitis B,hepatitis C,human immunodeficiency virus,and syphilis among street children residing in southern Tehran,Iran.Arch Iran Med 2006;9:153-155[PMID16649359]
168 Karimi M,Ghavanini AA.Seroprevalence of hepatitis B hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz,Iran J Paediatr Child Health 2001;37:564-566[PMID:11903836DOI:10.1046/j.1440-1754.2001.00709.x]
169 Hajiani E,Hashemi J,Masjedizadeh R,Shayesteh AA,Idani E,Rajabi T.Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province,south-west of Iran:a casecontrol study.World J Gastroenterol 2006;12:4884-4887[PMID16937474]
170 Hosseini Asl SK,Avijgan M,Mohamadnejad M.High Prevalence of HBV,HCV,and HIV Infections:In Gypsy Population Residing In Shar-e-kord.Arch Iran Med 2004;7:22-24
171 Gholamreza R,Shahryar S,Abbasali K,Hamidreza J,Abdolvahab M,Khodaberdi K,Danyal R,Nafiseh A.Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population Indian J Med Sci 2007;61:263-268[PMID:17478956 DOI10 .4103/0019-5359.32092]
172 Al-Kubaisy WA,Niazi AD,Kubba K.History of miscarriage as a risk factor for hepatitis C virus infection in pregnant Iraqi women.East Mediterr Health J 2002;8:239-244[PMID15339110]
173 Ameen R,Sanad N,Al-Shemmari S,Siddique I,Chowdhury RI,Al-Hamdan S,Al-Bashir A.Prevalence of viral markers among first-time Arab blood donors in Kuwait.Transfusion 2005;45:1973-1980[PMID:16371052 DOI:10.1111/j.1537-2995.2005.00635.x]
174 Chehadeh W,Kurien SS,Abdella N,Ben-Nakhi A,AlArouj M,Almuaili T,Al-Mutairi O,Al-Nakib W.Hepatitis C virus infection in a population with high incidence of type 2 diabetes:impact on diabetes complications.J Infect Public Health 2011;4:200-206[PMID:22000848 DOI:10.1016/j.jiph.2011.05.004]
175 Tamim H,Irani-Hakime N,Aoun JP,Khoury S,Samaha H,Almawi WY.Seroprevalence of hepatitis C virus(HCV)infection among blood donors:a hospital-based study.Transfus Apher Sci 2001;24:29-35[PMID:11515608 DOI:10.1016/S0955-3886(00)00124-7]
176 Irani-Hakime N,Tamim H,Samaha H,Almawi WY.Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon,1997-2000.Clin Lab Haematol 2001;23:317 -323[PMID:11703415]
177 Irani-Hakime N,Musharrafieh U,Samaha H,Almawi WY.Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon,1997-2003.Am J Infect Control 2006;34:241-243[PMID:16679184 DOI:10 .1016/j.ajic.2005.06.009]
178 Araj GF,Kfoury-Baz EE,Barada KA,Nassif RE,Alami SY.Hepatitis C virus:prevalence in Lebanese blood donors and brief overview of the disease.J Med Liban 1995;43:11-16[PMID:8676356]
179 Baddoura R,Haddad C,Germanos M.Hepatitis B and C seroprevalence in the Lebanese population.East Mediterr Health J 2002;8:150-156[PMID:15330570]
180 Daw MA,Elkaber MA,Drah AM,Werfalli MM,Mihat AA,Siala IM.Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk.Saudi Med J 2002;23:1356-1360[PMID:12506296]
181 Elzouki AN,Beeching NJ,Mutton KJ,Garson JA.Anti-HCV antibodies and HCV RNA in Libyan blood donors.Vox Sang1995;68:65[PMID:7536992 DOI:10.1111/j.1423-0410.1995.tb02551.x]
182 Saleh MG,Pereira LM,Tibbs CJ,Ziu M,al-Fituri MO,Williams R,McFarlane IG.High prevalence of hepatitis C virus in the normal Libyan population.Trans R Soc Trop Med Hyg1994;88:292-294[PMID:7974663 DOI:10.1016/0035-9203(94)90082-5]
183 Shabash A,Habas M,Alhajrasi A,Furarah A,Bouzedi A,Daw M.Forecast modelling for prediction of hepatitis B and hepatitis C seropositivity among Libyan population.Clin Microbiol Infect 2010;16:S310
184 Daw MA,El-Bouzedi A.Prevalence of hepatitis B and hepatitis C infection in Libya:results from a national population based survey.BMC Infect Dis 2014;14:17[PMID:24405790DOI:10.1186/1471-2334-14-17]
185 Benjelloun S,Bahbouhi B,Sekkat S,Bennani A,Hda N,Benslimane A.Anti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groups.Res Virol 1996;147:247-255[PMID:8837233]
186 Zohoun A,Hadef R,Zahid H,Benkirane M.[Seroprevalence of HBV and HCV in blood donors at the Blood Transfusion Center of Mohammed V Military Teaching Hospital in Rabat Morocco].Med Trop(Mars)2011;71:513-514[PMID:22235634]
187 Lahlou Amine I,Zouhair S,Chegri M,L’kassmi H.[Seroprevalence of anti-HCV in patients of the Military Hospital Moulay Ismail(Meknes,Morocco):Data analysis of the medical biology laboratory(2002-2005)].Bull Soc Pathol Exot2010;103:255-258[PMID:20596810 DOI:10.1007/s13149-010 -0064-x]
188 Aqodad N,Lahbabi M,Elyousfi M,Mellouki I,Benajah D,Elabkari M,Ibrahimi A.Prevalence of VHC-Ab and HBsAg among blood donors in Guelmim in the south of Morocco.Hepat Inter 2011;5:96[DOI:10.1007/s12072-010-9241-z]
189 WHO/EMRO.Regional database on HIV/AIDS.WHO Regional Office for the Eastern Mediterranean.2013.Available from:URL:http://www.emro.who.int/press-releases/2013/launch-of-a-new-who-hiv-campaign.html
190 al-Dhahry SH,Aghanashinikar PN,al-Hasani MK,Buhl MR,Daar AS.Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease.Infection 1993;21:164 -167[PMID:7690010 DOI:10.1007/BF01710538]
191 Alnaqy A,Al-Harthy S,Kaminski G,Al-Dhahry S.Detection of serum antibodies to hepatitis C virus in‘false-seronegative’blood donors in Oman.Med Princ Pract 2006;15:111-113[PMID:16484837 DOI:10.1159/000090914]
192 Schuster H,Serebour E,Nograles J,Al-Belushi I,Hassan K.Prevelance of blood-borne viruses amongst antenatal clinic patients and blood donors in a tertiary referral hospital in Oman.Clin Microbiol Infect 2009;15:S587
193 Pathare N,Al Abri SR,Al Siyabi B,Serebour F,Pathare A,Alkindi S.Seroprevalence of HBSAG,HCV,HIV,HBV PCR and RPR affecting the donor deferral patterns.Transfusion2012;52:216A
194 Abdul Mujeeb S,Aamir K,Mehmood K.Seroprevalence of HBV,HCV and HIV infections among college going first time voluntary blood donors.J Pak Med Assoc 2000;50:269 -270[PMID:10992712]
195 Mujeeb SA,Aamir K,Mehmood K.Seroprevalence of HBV,HCV and HIV infections among college going first time voluntary blood donors.J Pak Med Assoc 2006;56:S24-S25[PMID:16689479]
196 Kakepoto GN,Bhally HS,Khaliq G,Kayani N,Burney IA,Siddiqui T,Khurshid M.Epidemiology of blood-borne viruses:a study of healthy blood donors in Southern Pakistan.Southeast Asian J Trop Med Public Health 1996;27:703-706[PMID:9253870]
197 Akhtar S,Younus M,Adil S,Jafri SH,Hassan F.Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi,Pakistan.J Viral Hepat 2004;11:527-535[PMID:15500553 DOI:10.1111/j.1365-2893.2004.00518.x]
198 Sultan F,Mehmood T,Mahmood MT.Infectious pathogens in volunteer and replacement blood donors in Pakistan:a ten-year experience.Int J Infect Dis 2007;11:407-412[PMID:17331775 DOI:10.1016/j.ijid.2006.10.004]
199 Abdul Mujeeb S,Nanan D,Sabir S,Altaf A,Kadir M.Hepatitis B and C infection in first-time blood donors in Karachi--a possible subgroup for sentinel surveillance.East Mediterr Health J 2006;12:735-741[PMID:17333817]
200 Khattak MF,Salamat N,Bhatti FA,Qureshi TZ.Seroprevalence of hepatitis B,C and HIV in blood donors in northern Pakistan.J Pak Med Assoc 2002;52:398-402[PMID:12532573]
201 Ahmad N,Asgher M,Shafique M,Qureshi JA.An evidence of high prevalence of Hepatitis C virus in Faisalabad,Pakistan.Saudi Med J 2007;28:390-395[PMID:17334466]
202 Jafri W,Jafri N,Yakoob J,Islam M,Tirmizi SF,Jafar T,Akhtar S,Hamid S,Shah HA,Nizami SQ.Hepatitis B and C:prevalence and risk factors associated with seropositivity among children in Karachi,Pakistan.BMC Infect Dis 2006;6:101 [PMID:16792819 DOI:10.1186/1471-2334-6-101]
203 Agboatwalla M,Isomura S,Miyake K,Yamashita T,Morishita T,Akram DS.Hepatitis A,B and C seroprevalence in Pakistan.Indian J Pediatr 1994;61:545-549[PMID:7538098DOI:10.1007/BF02751716]
204 Akhtar S,Moatter T,Azam SI,Rahbar MH,Adil S.Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi,Pakistan.J Viral Hepat 2002;9:309-314[PMID:12081609 DOI:10.1046/j.1365-2893.2002.00350.x]
205 Parker SP,Khan HI,Cubitt WD.Detection of antibodies to hepatitis C virus in dried blood spot samples from mothers and their offspring in Lahore,Pakistan.J Clin Microbiol 1999;37 :2061-2063[PMID:10325381]
206 Aslam M,Aslam J.Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan.J Clin Gastroenterol 2001;33:407-411[PMID:11606859 DOI:10 .1097/00004836-200111000-00013]
207 Lema AM,Cox EA.Hepatitis C antibodies among blood donors in Qatar.Vox Sang 1992;63:237[PMID:1333139 DOI:10 .1111/j.1423-0410.1992.tb05110.x]
208 Fawzi Z,Al Hilali A,Al Malki A,Al Matawa H,Yousef B,Ali Bin Ali A,Al Mansour S.Survey of hepatitis markers among donors in the State of Qatar.Qatar Med J 2007;16:47-50
209 Sharma M,Matar K,Dweik NA,Kaabi SA,John AK,Mohannadi MA,Derbala MF,Amin AA,Pasic F,Yakoob R,ButtT.Early detection of hepatitis C using a one minute visual qualitative based kit system in a community based setting in Doha,Qatar.J Hepatol 2010;52:S260
210 Mahaba H,el-Tayeb Ael-K,Elbaz H.The prevalence of antibodies to hepatitis C virus in Hail region,Saudi Arabia.J Egypt Public Health Assoc 1999;74:69-80[PMID:17216953]
211 Bashawri LA,Fawaz NA,Ahmad MS,Qadi AA,Almawi WY.Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia,1998-2001.Clin Lab Haematol 2004;26:225-228[PMID:15163322 DOI:10.1111/j.1365-2257.2004.00601.x]
212 El-Hazmi MM.Prevalence of HBV,HCV,HIV-1,2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.Saudi Med J 2004;25 :26-33[PMID:14758374]
213 Abdelaal M,Rowbottom D,Zawawi T,Scott T,Gilpin C.Epidemiology of hepatitis C virus:a study of male blood donors in Saudi Arabia.Transfusion 1994;34:135-137[PMID:8310483 DOI:10.1046/j.1537-2995.1994.34294143941.x]
214 Al-Mofarreh M,Fakunle YM,El-Karamany WM,Ezzat HO,Ballesteros MN,Khawaji MZ,El-Drees AZ.Prevalence of antibodies to hepatitis C virus in blood donors in Riyadh.Ann Saudi Med 1991;11:501-503[PMID:17590781]
215 Bernvil SS,Andrews VJ,Kariem AA.Hepatitis C antibody prevalence in Saudi Arabian blood donor population.Ann Saudi Med 1991;11:563-567[PMID:17590794]
216 Al-Knawy B,El Mekki AA,Hamdi J,Thiga R,Sheikha A.Prevalence of antibody to hepatitis C virus in Saudi blood donors,Prevalence De L’anticorps Anti-Virus De L’hepatite C Chez Des Donneurs De Sang Saoudiens.Can J Gastroenterol1995;9:141-143
217 al-Sohaibani MO,al-Sheikh EH,al-Ballal SJ,Mirghani MA,Ramia S.Occupational risk of hepatitis B and C infections in Saudi medical staff.J Hosp Infect 1995;31:143-147[PMID:8551020]
218 Halawani M,Bakir TM.Determination of hepatitis C virus genotypes in pruritus patients in saudi arabia.Genet Test Mol Biomarkers 2012;16:46-49[PMID:21967468 DOI:10.1089/gtmb.2011.0064]
219 al Nasser MN.Intrafamilial transmission of hepatitis C virus(HCV):a major mode of spread in the Saudi Arabia population.Ann Trop Paediatr 1992;12:211-215[PMID:1381898]
220 Njoh J,Zimmo S.Prevalence of antibodies to hepatitis C virus in drug-dependent patients in Jeddah,Saudi Arabia.East Afr Med J 1997;74:89-91[PMID:9185392]
221 Fakeeh M,Zaki AM.Hepatitis C:prevalence and common genotypes among ethnic groups in Jeddah,Saudi Arabia.Am J Trop Med Hyg 1999;61:889-892[PMID:10674665]
222 Bahakim H,Bakir TM,Arif M,Ramia S.Hepatitis C virus antibodies in high-risk Saudi groups.Vox Sang 1991;60:162 -164[PMID:1907415 DOI:10.1111/j.1423-0410.1991.tb00894.x]
223 al Karawi MA,Shariq S,el Shiekh Mohamed AR,Saeed AA,Ahmed AM.Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia.J Gastroenterol Hepatol 1992;7:237-239[PMID:1319221 DOI:10 .1111/j.1440-1746.1992.tb00970.x]
224 Nur YA,Groen J,Elmi AM,Ott A,Osterhaus AD.Prevalence of serum antibodies against bloodborne and sexually transmitted agents in selected groups in Somalia.Epidemiol Infect 2000;124:137-141[PMID:10722141 DOI:10.1017/S0950268899003441]
225 Bile K,Aden C,Norder H,Magnius L,Lindberg G,Nilsson L.Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia.Scand J Infect Dis 1993;25:559 -564[PMID:7506842 DOI:10.3109/00365549309008543]
226 McCarthy MC,el-Tigani A,Khalid IO,Hyams KC.Hepatitis B and C in Juba,southern Sudan:results of a serosurvey.Trans R Soc Trop Med Hyg 1994;88:534-536[PMID:7992329DOI:10.1016/0035-9203(94)90150-3]
227 Elsheikh RM,Daak AA,Elsheikh MA,Karsany MS,AdamI.Hepatitis B virus and hepatitis C virus in pregnant Sudanese women.Virol J 2007;4:104[PMID:17958904 DOI:10 .1186/1743-422X-4-104]
228 Othman BM,Monem FS.Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus,Syria.Saudi Med J 2002;23:393-395[PMID:11953762]
229 Hatira SA,Yacoub-Jemni S,Houissa B,Kaabi H,Zaeir M,Kortas M,Ghachem L.[Hepatitis C virus antibodies in 34130blood donors in Tunisian Sahel].Tunis Med 2000;78:101-105[PMID:10894044]
230 Slama H,Mojaat N,Dahri R,Boukef K.[Epidemiologic study of anti-HCV antibodies in Tunisian blood donors].Rev Fr Transfus Hemobiol 1991;34:459-464[PMID:1663358 DOI:10 .1016/S1140-4639(05)80140-6]
231 Mejri S,Salah AB,Triki H,Alaya NB,Djebbi A,Dellagi K.Contrasting patterns of hepatitis C virus infection in two regions from Tunisia.J Med Virol 2005;76:185-193[PMID:15834884 DOI:10.1002/jmv.20342]
232 Gorgi Y,Yalaoui S,Ben Nejma HL,Azzouz MM,Hsairi M,Ben Khelifa H,Ayed K.[Detection of hepatitis C virus in the general population of Tunisia].Bull Soc Pathol Exot 1998;91:177 [PMID:9642480]
233 Triki H,Said N,Ben Salah A,Arrouji A,Ben Ahmed F,Bouguerra A,Hmida S,Dhahri R,Dellagi K.Seroepidemiology of hepatitis B,C and delta viruses in Tunisia.Trans R Soc Trop Med Hyg 1997;91:11-14[PMID:9093616 DOI:10.1016/S0035-9203(97)90374-6]
234 Ozsoy MF,Oncul O,Cavuslu S,Erdemoglu A,Emekdas G,Pahsa A.Seroprevalences of hepatitis B and C among health care workers in Turkey.J Viral Hepat 2003;10:150-156[PMID:12614472 DOI:10.1046/j.1365-2893.2003.00404.x]
235 Gurol E,Saban C,Oral O,Cigdem A,Armagan A.Trends in hepatitis B and hepatitis C virus among blood donors over16 years in Turkey.Eur J Epidemiol 2006;21:299-305[PMID:16685581 DOI:10.1007/s10654-006-0001-2]
236 Sakarya S,Oncu S,Ozturk B,Oncu S.Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey.Saudi Med J 2004;25:1070-1072[PMID:15322600]
237 Altindis M,Yilmaz S,Dikengil T,Acemoglu H,Hosoglu S.Seroprevalence and genotyping of hepatitis B,hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus.World J Gastroenterol 2006;12:6792-6796[PMID:17106927]
238 Mutlu B,MeriM,Willke A.[Seroprevalence of hepatitis B and C virus,human immunodeficiency virus and syphilis in the blood donors].Mikrobiyol Bul 2004;38:445-448[PMID:15700672]
239 Afsar I,Gungor S,Sener AG,Yurtsever SG.The prevalence of HBV,HCV and HIV infections among blood donors in Izmir,Turkey.Indian J Med Microbiol 2008;26:288-289[PMID:18695343 DOI:10.4103/0255-0857.42074]
240 Gulcan A,Gulcan E,Toker A,Bulut I,Akcan Y.Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients in Kutahya,Turkey.J Investig Med 2008;56:858-863[PMID:18667903 DOI:10.231/JIM.0b013e3181788d28]
241 Alim A,Artan MO,Baykan Z,Alim BA.Seroprevalence of hepatitis B and C viruses,HIV,and syphilis infections among engaged couples.Saudi Med J 2009;30:541-545[PMID:19370284 DOI:2009008’]
242 Tahan V,Karaca C,Yildirim B,Bozbas A,Ozaras R,Demir K,Avsar E,Mert A,Besisik F,Kaymakoglu S,Senturk H,Cakaloglu Y,Kalayci C,Okten A,Tozun N.Sexual transmission of HCV between spouses.Am J Gastroenterol 2005;100:821-824[PMID:15784025 DOI:10.1111/j.1572-0241.2005.40879.x]
243 Bozkurt H,Kurtoglu MG,Bayram Y,Kesli R,Berktas M.Distribution of hepatitis C prevalence in individuals according to their age level in Eastern Turkey.Eur J Gastroenterol Hepatol 2008;20:1249[PMID:18989151 DOI:10.1097/MEG.0b013e328305ba19]
244 Yildirim B,Barut S,Bulut Y,Yeniehirli G,Ozdemir M,Cetin I,Etikan I,AkbaA,AtiO,Ozyurt H,Sahin S.Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey:A populationbased study.Turk J Gastroenterol 2009;20:27-30[PMID:19330732]
245 Tekay F,Ozbek E.[Short communication:hepatitis B,hepatitis C and human immunodeficiency virus seropositivities in women admitted to Sanliurfa Gynecology and Obstetrics Hospital].Mikrobiyol Bul 2006;40:369-373[PMID:17205695]
246 Demirtürk N,Demirdal T,Toprak D,AltindiM,Aktepe OC.Hepatitis B and C virus in West-Central Turkey:seroprevalence in healthy individuals admitted to a university hospital for routine health checks.Turk J Gastroenterol2006;17:267-272[PMID:17205404]
247 Akcam FZ,Uskun E,Avsar K,Songur Y.Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey.Int J Infect Dis 2009;13:274 -284[PMID:18945630 DOI:10.1016/j.ijid.2008.07.005]
248 Al Shaer L,AbdulRahman M,John TJ,AlHashimi A.Trends in prevalence,incidence,and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors:impact of individual-donation nucleic acid testing,2004 through 2009.Transfusion 2012;52:2300-2309[PMID:22691239 DOI:10.1111/j.1537-2995.2012.03740.x]
249 Raouf M,Al Amiri A,Gammon R.Demographic profile of blood donors and its influence on the safety of blood transfusion in the United Arab Emirates.Transfusion 2010;50:205A[DOI:10.1111/j.1537-2995.2010.02833-1.x]
250 Sheek-Hussein M,Hashmey R,Alsuwaidi AR,Al Maskari F,Amiri L,Souid AK.Seroprevalence of measles,mumps,rubella,varicella-zoster and hepatitis A-C in Emirati medical students.BMC Public Health 2012;12:1047[PMID:23217121DOI:10.1186/1471-2458-12-1047]
251 Fakhry SM,Al Dawilah TA,Mehta SH.Prevalence of hepatitis B virus(HBV)and hepatitis C virus(HCV)in young adults in United Arab Emirates(UAE).Hepatology 2011;54:607 A[DOI:10.1002/hep.24666]
252 Haidar NA.Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah,Yemen Republic.Saudi Med J 2002;23:1090-1094[PMID:12370719]
253 el Guneid AM,Gunaid AA,O’Neill AM,Zureikat NI,Coleman JC,Murray-Lyon IM.Prevalence of hepatitis B,C,and D virus markers in Yemeni patients with chronic liver disease.J Med Virol 1993;40:330-333[PMID:8228926 DOI:10 .1002/jmv.1890400413]
254 Al-Moslih MI,Al-Huraibi MA.Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen.East Mediterr Health J 2001;7:771-778[PMID:15332778]
255 Todd CS,Abed AM,Strathdee SA,Scott PT,Botros BA,Safi N,Earhart KC.HIV,hepatitis C,and hepatitis B infections and associated risk behavior in injection drug users,Kabul,Afghanistan.Emerg Infect Dis 2007;13:1327-1331[PMID:18252103 DOI:10.3201/eid1309.070036]
256 Qadi AA,Tamim H,Ameen G,Bu-Ali A,Al-Arrayed S,Fawaz NA,Almawi WY.Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia:a survey by serologic and molecular methods.Am J Infect Control 2004;32:493-495[PMID:15573057 DOI:10 .1016/j.ajic.2003.12.009]
257 al-Mahroos FT,Ebrahim A.Prevalence of hepatitis B,hepatitis C and human immune deficiency virus markers among patients with hereditary haemolytic anaemias.Ann Trop Paediatr 1995;15:121-128[PMID:7677412]
258 Waked IA,Saleh SM,Moustafa MS,Raouf AA,Thomas DL,Strickland GT.High prevalence of hepatitis C in Egyptian patients with chronic liver disease.Gut 1995;37:105-107[PMID:7545630 DOI:10.1136/gut.37.1.105]
259 Mabrouk GM.Prevalence of hepatitis C infection and schistosomiasis in Egyptian patients with hepatocellular carci-noma.Dis Markers 1997;13:177-182[PMID:9405930]
260 Hindy AM,Abdelhaleem ES,Aly RH.Hepatitis B and C viruses among Egyptian dentists.Egypt Dent J 1995;41:1217-1226[PMID:9497659]
261 Gohar SA,Khalil RY,Elaish NM,Khedr EM,Ahmed MS.Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients.J Egypt Public Health Assoc 1995;70:465-484[PMID:17214170]
262 Hassan AA,Khalil R.Hepatitis C in dialysis patients in egypt:relationship to dialysis duration,blood transfusion,and liver disease.Saudi J Kidney Dis Transpl 2000;11:72-73[PMID:18209303]
263 El Yazeed SA,EL-G NA,Younes K,El-Ghobary A.Antiphospholipid antibodies in Egyptian patients with chronic renal failure.J Med Sci 2006;6:468-473
264 Saleh E,McFarland W,Rutherford G,Mandel J,El-Shazaly M,Coates T.Sentinel surveillance for HIV and markers for high risk behaviors among STD clinic attendees in Alexandria,Egypt.XIII International AIDS Conference,Durban,South Africa,Poster MoPeC2398.Proceedings of the XIII International AIDS Conference;2000.Available from:URL:http://caps.ucsf.edu/uploads/pubs/presentations/pdf/saleh.pdf
265 Quinti I,el-Salman D,Monier MK,Hackbart BG,Darwish MS,el-Zamiaty D,Paganelli R,Pandolfi F,Arthur RR.HCV infection in Egyptian patients with acute hepatitis.Dig Dis Sci 1997;42:2017-2023[PMID:9365128 DOI:10.1023/A:1018897813268]
266 Gheith OA,Saad MA,Hassan AA,A-Eldeeb S,Agroudy AE,Sheashaa H,Ghoneim MA.Hepatic dysfunction in kidney transplant recipients:prevalence and impact on graft and patient survival.Clin Exp Nephrol 2007;11:309-315[PMID:18085393 DOI:10.1007/s10157-007-0490-7]
267 Tonbary YA,Elashry R,Zaki Mel S.Descriptive epidemiology of hemophilia and other coagulation disorders in mansoura,egypt:retrospective analysis.Mediterr J Hematol Infect Dis 2010;2:e2010025[PMID:21415978 DOI:10.4084/mjhid.2010.025]
268 Said ZN,El-Sayed MH,El-Bishbishi IA,El-Fouhil DF,Abdel-Rheem SE,El-Abedin MZ,Salama II.High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.Liver Int 2009;29:518-524[PMID:19192168 DOI:10.1111/j.1478-3231.2009.01975.x]
269 El-Faramawy AA,El-Rashidy OF,Tawfik PH,Hussein GH.Transfusion transmitted hepatitis:where do we stand nowA one center study in upper egypt.Hepat Mon 2012;12:286 -291[PMID:22690237 DOI:10.5812/hepatmon.852]
270 Mansour AK,Aly RM,Abdelrazek SY,Elghannam DM,Abdelaziz SM,Shahine DA,Elmenshawy NM,Darwish AM.Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients.Hematol Oncol Stem Cell Ther 2012;5:54-59[PMID:22446611 DOI:10.5144/1658-3876.2012.54]
271 Omar N,Salama K,Adolf S,El-Saeed GS,Abdel Ghaffar N,Ezzat N.Major risk of blood transfusion in hemolytic anemia patients.Blood Coagul Fibrinolysis 2011;22:280-284[PMID:21508832 DOI:10.1097/MBC.0b013e3283451255]
272 Ali F,Abdel-Aziz A,Helmy MF,Abdel-Mobdy A,Darwish M.Prevalence of certain sexually transmitted viruses in Egypt.J Egypt Public Health Assoc 1998;73:181-192[PMID:17219920]
273 Jahani MR,Alavian SM,Shirzad H,Kabir A,Hajarizadeh B.Distribution and risk factors of hepatitis B,hepatitis C,and HIV infection in a female population with“illegal social behaviour”.Sex Transm Infect 2005;81:185[PMID:15800109DOI:10.1136/sti.2004.011114]
274 Semnani S,Roshandel G,Abdolahi N,Besharat S,Keshtkar AA,Joshaghani H,Moradi A,Kalavi K,Jabbari A,Kabir MJ,Hosseini SA,Sedaqat SM,Danesh A,Roshandel D.Hepatitis B/C virus co-infection in Iran:a seroepidemiological study.Turk J Gastroenterol 2007;18:20-21[PMID:17450490]
275 Rais-Jalali G,Khajehdehi P.Anti-HCV seropositivity among haemodialysis patients of Iranian origin.Nephrol Dial Transplant 1999;14:2055-2056[PMID:10462312]
276 Nobakht Haghighi A,Zali MR,Nowroozi A.Hepatitis C antibody and related risk factors in hemodialysis patients in Iran.J Am Soc Nephrol 2001;12:233A
277 Khamispoor G,Tahmasebi R.Prevalence of HIV,HBV,HCV and syphilis in high risk groups of Bushehr province(Farsi).Iran South Med J 1999;1:59-53
278 Mohammad Alizadeh AH,Alavian SM,Jafari K,Yazdi N.Prevalence Of Hbs Ag,Hc Ab&Hiv Ab In The Addict Prisoners Of Hammadan Prison(Iran,1998).J Resear Med Sci2003;7:311-313
279 Amiri ZM,Shakib AJ,Toorchi M.Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan,Islamic Republic of Iran.East Mediterr Health J 2005;11:372 -376[PMID:16602456]
280 Sharifi-Mood B,Alavi-Naini R,Salehi M,Hashemi M,Rakhshani F.Spectrum of clinical disease in a series of hospitalized HIV-infected patients from southeast of Iran.Saudi Med J 2006;27:1362-1366[PMID:16951774]
281 Alavian SM.Prevalence of HCV,HBV and HIV infection among hemophiliacs patients.HakimRes J 2003;6:45-51
282 Karimi M,Yarmohammadi H,Ardeshiri R,Yarmohammadi H.Inherited coagulation disorders in southern Iran.Haemophilia 2002;8:740-744[PMID:12410641 DOI:10.1046/j.1365-2516.2002.00699.x]
283 Torabi SA,Abed-Ashtiani K,Dehkhoda R,Moghadam AN,Bahram MK,Dolatkhah R,Babaei J,Taheri N.Prevalence of hepatitis B,C and HIV in hemophiliac patients of East Azarbaijan in 2004.Blood 2006;2(Suppl 7):291-299
284 Javadzadeh H,Attar M,Taher Yavari M.Study of the prevalence of HBV,HCV,and HIV infection in hemophilia and thalassemia population of Yazd(Farsi).Khoon(Blood)2006;2:315-322
285 Samimi-Rad K,Shahbaz B.Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province,Iran.Haemophilia 2007;13:156-163[PMID:17286768 DOI:10.1111/j.1365-2516.2006.01415.x]
286 Sharifi-Mood B,Eshghi P,Sanei-Moghaddam E,Hashemi M.Hepatitis B and C virus infections in patients with hemophilia in Zahedan,southeast Iran.Saudi Med J 2007;28:1516-1519[PMID:17914511]
287 Mansour-Ghanaei F,Fallah MS,Shafaghi A,Yousefi-Mashhoor M,Ramezani N,Farzaneh F,Nassiri R.Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan(northern province of Iran).Med Sci Monit 2002;8:CR797-CR800[PMID:12503038]
288 Alavian SM,Gholami B,Masarrat S.Hepatitis C risk factors in Iranian volunteer blood donors:a case-control study.J Gastroenterol Hepatol 2002;17:1092-1097[PMID:12201870DOI:10.1046/j.1440-1746.2002.02843.x]
289 Nakhaie S,Talachian E.Prevalence and characteristic of liver involvement in thalassemia patients with HCV in AliAsghar children hospital,Tehran,Iran(Farsi).J of Iran Univ Med Sci 2003;37:799-806
290 Kadivar MR,Mirahmadizadeh AR,Karimi A,Hemmati A.The prevalence of HCV and HIV in thalassemia patients in Shiraz,Iran.Med J Iran Hosp 2001;4:18-20
291 Basiratnia M,HosseiniAsl SMK,Avijegan M.Hepatitis C prevalence in thalassemia patients in Sharkord,Iran(Farsi).Shahr Univ Med Sci J 1999;4:13-18
292 Jafroodi M,Asadi R.Prevalence of HCV in thalassemia major patients in Guilan province,Iran.The 4th congress of Iranian Pediatric Hematology;Oncology Society;Sep 2006
293 Kashef S,Karimi M,Amirghofran Z,Ayatollahi M,Pasalar M,Ghaedian MM,Kashef MA.Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients.Int J Lab Hematol 2008;30:11-16[PMID:18190462]
294 Talaie H,Shadnia SH,Okazi A,Pajouhmand A,Hasanian H,Arianpoor H.The prevalence of hepatitis B,hepatitis C and HIV infections in non-IV drug opioid poisoned patients in Tehran-Iran.Pak J Biol Sci 2007;10:220-224[PMID:19070018DOI:10.3923/pjbs.2007.220.224]
295 Kheirandish P,SeyedAlinaghi S,Jahani M,Shirzad H,Seyed Ahmadian M,Majidi A,Sharifi A,Hosseini M,Mohraz M,McFarland W.Prevalence and correlates of hepatitis C infection among male injection drug users in detention,Tehran,Iran.J Urban Health 2009;86:902-908[PMID:19844670 DOI:10 .1007/s11524-009-9393-0]
296 Zamani S,Ichikawa S,Nassirimanesh B,Vazirian M,Ichikawa K,Gouya MM,Afshar P,Ono-Kihara M,Ravari SM,Kihara M.Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.Int J Drug Policy 2007;18:359-363[PMID:17854723 DOI:S0955-3959(07)00042-4]
297 Khani M,Vakili MM.Prevalence and risk factors of HIV,hepatitis B virus,and hepatitis C virus infections in drug addicts among Zanjan prisoners.Arch Iran Med 2003;6:1-4
298 Zali MR,Aghazadeh R,Nowroozi A,Amir-Rasouly H.AntiHCV antibody among Iranian IV drug users:is it a serious problem.Arch Iran Med 2001;4:115-119
299 Imani R,Karimi A,Rouzbahani R,Rouzbahani A.Seroprevalence of HBV,HCV and HIV infection among intravenous drug users in Shahr-e-Kord,Islamic Republic of Iran.East Mediterr Health J 2008;14:1136-1141[PMID:19161086]
300 Mohtasham Amiri Z,Rezvani M,Jafari Shakib R,Jafari Shakib A.Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.East Mediterr Health J 2007;13:250-256[PMID:17684845]
301 Javadi AA,Avijgan M,Hafizi M.Prevalence of HBV and HCV Infections and Associated Risk Factors in Addict Prisoners.Iran J Public Health 2006;35:33-36
302 Al-Kubaisy WA,Al-Naib KT,Habib MA.Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad.East Mediterr Health J 2006;12:264-269[PMID:17037693]
303 Al-Kubaisy WA,Al-Naib KT,Habib M.Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia.East Mediterr Health J 2006;12:204-210[PMID:17037239]
304 Al-Sheyyab M,Batieha A,El-Khateeb M.The prevalence of hepatitis B,hepatitis C and human immune deficiency virus markers in multi-transfused patients.J Trop Pediatr 2001;47:239 -242[PMID:11523766 DOI:10.1093/tropej/47.4.239]
305 al-Nakib B,Koshy A,Kaloui M,al-Ramahi S,al-Mufti S,Radhakrishnan S,al-Nakib W.Hepatitis C virus antibody in Kuwait.Vox Sang 1992;63:75-76[PMID:1384237 DOI:10 .1111/j.1423-0410.1992.tb01224.x]
306 Kapoor M,el-Reshaid K,al-Mufti S,Sanad NA,Koshy A.Is dialysis environment more important than blood transfusion in transmission of hepatitis C virus during hemodialysisVox Sang 1993;65:331[PMID:7508661 DOI:10.1111/j.1423-0410.1993.tb02176.x]
307 El-Reshaid K,Kapoor M,Sugathan T,Al-Mufti S,Al-Hilali N.Hepatitis C virus infection in patients on maintenance dialysis in kuwait:epidemiological profile and efficacy of prophylaxis.Saudi J Kidney Dis Transpl 1995;6:144-150[PMID:18583854]
308 al-Fuzae L,Aboolbacker KC,al-Saleh Q.beta-Thalassaemia major in Kuwait.J Trop Pediatr 1998;44:311-312[PMID:9819498 DOI:10.1093/tropej/44.5.311]
309 Irani-Hakime N,Aoun J,Khoury S,Samaha HR,Tamim H,Almawi WY.Seroprevalence of hepatitis C infection among health care personnel in Beirut,Lebanon.Am J Infect Control 2001;29:20-23[PMID:11172314 DOI:10.1067/mic.2001.110777]
310 Ramia S,Mokhbat J,Sibai A,Klayme S,Naman R.Exposure rates to hepatitis C and G virus infections among HIVinfected patients:evidence of efficient transmission of HGV by the sexual route.Int J STD AIDS 2004;15:463-466[PMID:15228731]
311 Alashek W,McIntyre C,Taal M.Morbidity of diabetic end-stage kidney disease patients treated by dialysis in Libya.Diabetes Obes Metab 2010;12:76-77[DOI:10.1111/j.1463-1326.2010.01284.x]
312 Franka E,El-Zoka AH,Hussein AH,Elbakosh MM,Arafa AK,Ghenghesh KS.Hepatitis B virus and hepatitis C virus in medical waste handlers in Tripoli,Libya.J Hosp Infect 2009;72 :258-261[PMID:19443080 DOI:10.1016/j.jhin.2009.03.019]
313 El-Zouki AY,Bendard AB,Sharif MS.HCV in hemodialysis patients in Benghazi,Libya.Ann Saudi Med 1993;13:203[PMID:17590656]
314 Belbacha I,Cherkaoui I,Akrim M,Dooley KE,El Aouad R.Seroprevalence of hepatitis B and C among barbers and their clients in the Rabat region of Morocco.East Mediterr Health J2011;17:911-919[PMID:22355943]
315 Radoui A,Skalli Z,Haddiya I,Benamar L,Ezzaitouni F,Ouzeddoun N,Bayahia R,Rhou H.Prevalence and predictive factors of anemia after renal transplantation:a Moroccan report.Transplant Proc 2010;42:3542-3549[PMID:21094812DOI:10.1016/j.transproceed.2010.07.092]
316 Boulaajaj K,Elomari Y,Elmaliki B,Madkouri B,Zaid D,Benchemsi N.[Prevalence of hepatitis C,hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital,Casablanca].Nephrol Ther 2005;1:274-284[PMID:16895696]
317 El Khorassani M,Kababri M,Hessissen L,Khattab M,Kili A.Hemophilia in Morocco:Current state and prospects.Haemophilia 2010;16:61[DOI:10.1111/j.1365-2516.2010.02283.x]
318 Bousfiha AA,Hachim J,Benjelloun S,Benslimane A,Mikou N,Hadj Khalifa H.Prevalence of infection with the hepatitis B and C viruses and the human immunodeficiency virus in39 Maroccan children with hemophilia.Annales de Pediatrie1999;46:199-204
319 Oman Ministry of Health.HIV Risk among Heroin and Injecting Drug Users in Muscat,Oman:Quantitative Survey.Preliminary Data 2006
320 Abdul Mujeeb S,Jamal Q,Khanani R,Iqbal N,Kaher S.Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi,Pakistan.Trop Doct 1997;27:45-46[PMID:9030022]
321 Mujeeb SA,Khatri Y,Khanani R.Frequency of parenteral exposure and seroprevalence of HBV,HCV,and HIV among operation room personnel.J Hosp Infect 1998;38:133-137[PMID:9522291 DOI:10.1016/S0195-6701(98)90066-4]
322 Aziz S,Memon A,Tily HI,Rasheed K,Jehangir K,Quraishy MS.Prevalence of HIV,hepatitis B and C amongst health workers of Civil Hospital Karachi.J Pak Med Assoc 2002;52:92 -94[PMID:12071075]
323 Gul A,Iqbal F.Prevalence of hepatitis C in patients on maintenance haemodialysis.J Coll Physicians Surg Pak 2003;13:15 -18[PMID:12685968]
324 Khan MS,Jamil M,Jan S,Zardad S,Sultan S,Sahibzada AS.Prevalence of hepatitis‘B’and‘C’in orthopaedics patients at Ayub Teaching Hospital Abbottabad.J Ayub Med Coll Abbottabad 2007;19:82-84[PMID:18693606]
325 Kuo I,ul-Hasan S,Galai N,Thomas DL,Zafar T,Ahmed MA,Strathdee SA.High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan.Harm Reduct J 2006;3:26[PMID:16914042 DOI:10 .1186/1477-7517-3-26]
326 United Nations Office for Drug Control and Crime Prevention,Joint United Nations Programme on HIV/AIDS.Baseline Study of the Relationship between Injecting Drug Use,HIV and Hepatitis C among Male Injecting Drug Users in Lahore.1999
327 Achakzai M,Kassi M,Kasi PM.Seroprevalences and coinfections of HIV,hepatitis C virus and hepatitis B virus in injecting drug users in Quetta,Pakistan.Trop Doct 2007;37:43 -45[PMID:17326891 DOI:10.1258/004947507779951989]
328 Pakistan National AIDS Control Programe.National Study of Reproductive Tract and Sexually Transmitted Infections.Survey of High Risk Groups in Lahore and Karachi.Pakistan:Ministry of Health,2005
329 Bhatti FA,Amin M,Saleem M.Prevalence of antibody to hepatitis C virus in Pakistani thalassaemics by particle agglutination test utilizing C 200 and C 22-3 viral antigen coated particles.J Pak Med Assoc 1995;45:269-271[PMID:8714623]
330 Akhtar S,Moatter T.Hepatitis C virus infection in polytransfused thalassemic children in Pakistan.Indian Pediatr2004;41:1072-1073[PMID:15523144]
331 Rizvi TJ,Fatima H.Frequency of hepatitis C in obstetric cases.J Coll Physicians Surg Pak 2003;13:688-690[PMID:15569552]
332 Khan AJ,Luby SP,Fikree F,Karim A,Obaid S,Dellawala S,Mirza S,Malik T,Fisher-Hoch S,McCormick JB.Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan.Bull World Health Organ 2000;78 :956-963[PMID:10994278]
333 Ali SS,Ali IS,Aamir AH,Jadoon Z,Inayatullah S.Frequency of hepatitis C infection in diabetic patients.J Ayub Med Coll Abbottabad 2007;19:46-49[PMID:17867480]
334 Abboud O,Rashid A,Al-Kaabi S.Hepatitis C virus infection in hemodialysis patients in qatar.Saudi J Kidney Dis Transpl1995;6:151-153[PMID:18583855]
335 Ayoola EA,al-Mofleh IA,al-Faleh FZ,al-Rashed R,Arif MA,Ramia S,Mayet I.Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases.Hepatogastroenterology 1992;39:337-339[PMID:1385286]
336 Khan ZA,Alkhalife IS,Fathalla SE.Prevalence of hepatitis C virus among bilharziasis patients.Saudi Med J 2004;25:204 -206[PMID:14968219]
337 Karkar A.Hepatitis C in dialysis units:the Saudi experience.Hemodial Int 2007;11:354-367[PMID:17576302 DOI:10.1111/j.1542-4758.2007.00192.x]
338 Saxena AK,Panhotra BR.The vulnerability of middleaged and elderly patients to hepatitis C virus infection in a high-prevalence hospital-based hemodialysis setting.J Am Geriatr Soc 2004;52:242-246[PMID:14728634 DOI:10.1111/j.1532-5415.2004.52062.x]
339 Huraib S,al-Rashed R,Aldrees A,Aljefry M,Arif M,alFaleh FA.High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia:a need for new dialysis strategies.Nephrol Dial Transplant 1995;10:470-474[PMID:7623989]
340 Souqiyyeh MZ,Shaheen FA,Huraib SO,Al-Khader AA.The annual incidence of seroconversion of antibodies to the hepatitis C virus in the hemodialysis population in saudi arabia.Saudi J Kidney Dis Transpl 1995;6:167-173[PMID:18583859]
341 Shaheen FA,Huraib SO,Al-Rashed R,Aldrees A,Arif M,Al Jeffry M,Tashkandy MA,Safwat M.Prevalence of hepatitis C antibodies among hemodialysis patients in the Western province of saudi arabia.Saudi J Kidney Dis Transpl 1995;6:136 -139[PMID:18583852]
342 Omar MN,Tashkandy MA,El Tonsy AH.Liver enzymes and protein electrophoretic patterns in hemodialysis patients with antibodies against the hepatitis C virus.Saudi J Kidney Dis Transpl 1995;6:163-166[PMID:18583858]
343 Ahmad MS,Mahtab AM,Abdullatif AS,Tashkandy MA,Kashreed MS,Maulana A.Prevalence of antibodies against the hepatitis C virus among voluntary blood donors at a makkah hospital.Saudi J Kidney Dis Transpl 1995;6:122-124[PMID:18583848]
344 Zaher G,Adam S.Outcomes of congenital bleeding disorders.Bahrain Medical Bulletin 2012;34:2
345 Al-Hawsawi ZM.Prevalence of hepatitis C virus antibody.Ann Saudi Med 2000;20:488-489[PMID:17264660]
346 al-Fawaz I,al-Rasheed S,al-Mugeiren M,al-Salloum A,alSohaibani M,Ramia S.Hepatitis E virus infection in patients from Saudi Arabia with sickle cell anaemia and beta-thalassemia major:possible transmission by blood transfusion.JViral Hepat 1996;3:203-205[PMID:8871882]
347 al-Fawaz I,Ramia S.Decline in hepatitis B infection in sickle cell anaemia and beta thalassaemia major.Arch Dis Child1993;69:594-596[PMID:8257183]
348 Harakati MS,Abualkhair OA,Al-Knawy BA.Hepatitis C Virus infection in Saudi Arab patients with B-cell nonHodgkin’s lymphoma.Saudi Med J 2000;21:755-758[PMID:11423889]
349 Watts DM,Corwin AL,Omar MA,Hyams KC.Low risk of sexual transmission of hepatitis C virus in Somalia.Trans R Soc Trop Med Hyg 1994;88:55-56[PMID:8154002]
350 El-Amin HH,Osman EM,Mekki MO,Abdelraheem MB,Ismail MO,Yousif ME,Abass AM,El-haj HS,Ammar HK.Hepatitis C virus infection in hemodialysis patients in Sudan:two centers’report.Saudi J Kidney Dis Transpl 2007;18:101 -106[PMID:17237901]
351 Kose S,Gurkan A,Akman F,Kelesoglu M,Uner U.Treatment of hepatitis C in hemodialysis patients using pegylated interferon alpha-2a in Turkey.J Gastroenterol 2009;44:353 -358[PMID:19277451 DOI:10.1007/s00535-009-0016-z]
352 Ati HA.HIV/AIDS/STIs Social and Geographical Mapping of Prisoners,Tea Sellers and Commercial Sex Workers in Port Sudan Town,Red Sea State.Sudan:Ockenden International,2005
353 Mudawi HM,Smith HM,Rahoud SA,Fletcher IA,Babikir AM,Saeed OK,Fedail SS.Epidemiology of HCV infection in Gezira state of central Sudan.J Med Virol 2007;79:383-385[PMID:17311341]
354 Othman BM,Monem FS.Prevalence of hepatitis C virus antibodies among health care workers in Damascus,Syria.Saudi Med J 2001;22:603-605[PMID:11479642 DOI:10.1002/jmv.20780]
355 Moukeh G,Yacoub R,Fahdi F,Rastam S,Albitar S.Epidemiology of hemodialysis patients in Aleppo city.Saudi J Kidney Dis Transpl 2009;20:140-146[PMID:19112237]
356 Kaabia N,Ben Jazia E,Slim I,Fodha I,Hachfi W,Gaha R,Khalifa M,Hadj Kilani A,Trabelsi H,Abdelaziz A,Bahri F,Letaief A.Association of hepatitis C virus infection and diabetes in central Tunisia.World J Gastroenterol 2009;15:2778-2781[PMID:19522029 DOI:10.3748/wjg.15.2778]
357 Kaabia N,Ben Jazia E,Hannachi N,Khalifa M,Dhouibi S,Dabbabi F,Boukadida J,Bahri F,Brahem A,Mrizak N,Letaief A.[Prevalence of hepatitis C virus among health care workers in central Tunisia].Med Mal Infect 2009;39:66-67[PMID:19041206 DOI:10.1016/j.medmal.2008.10.007]
358 Hmaied F,Ben Mamou M,Saune-Sandres K,Rostaing L,Slim A,Arrouji Z,Ben Redjeb S,Izopet J.Hepatitis C virus infection among dialysis patients in Tunisia:incidence and molecular evidence for nosocomial transmission.J Med Virol2006;78:185-191[PMID:16372289 DOI:10.1002/jmv.20526]
359 Hmida S,Mojaat N,Chaouchi E,Mahjoub T,Khlass B,Abid S,Boukef K.[HCV antibodies in hemodialyzed patients in Tunisia].Pathol Biol(Paris)1995;43:581-583[PMID:8570261]
360 Jemni S,Ikbel K,Kortas M,Mahjoub J,Ghachem L,Bidet JM,Boukef K.Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.Nouv Rev Fr Hematol 1994;36:349 -351[PMID:7534398]
361 Sassi F,Gorgi Y,Ayed K,Abdallah TB,Lamouchi A,Maiz HB.Hepatitis C virus antibodies in dialysis patients in Tunisia:a single center study.Saudi J Kidney Dis Transpl 2000;11:218 -222[PMID:18209319]
362 Kilani B,Ammari L,Marrakchi C,Letaief A,Chakroun M,Ben Jemaa M,Ben Assa HT,Kanoun F,Ben Chaabène T.Seroepidemiology of HCV-HIV coinfection in Tunisia.Tunis Med 2007;85:121-123[PMID:17665657]
363 Hannachi N,Boughammoura L,Marzouk M,Tfifha M,Khlif A,Soussi S,Skouri H,Boukadida J.[Viral infection risk in polytransfused adults:seroprevalence of seven viruses in central Tunisia].Bull Soc Pathol Exot 2011;104:220-225[PMID:21695497 DOI:10.1007/s13149-010-0103-7]
364 Djebbi A,Bahri O,Langar H,Sadraoui A,Mejri S,TrikiH.Genetic variability of genotype 1 hepatitis C virus isolates from Tunisian haemophiliacs.New Microbiol 2008;31:473 -480[PMID:19123302]
365 Langar H,Triki H,Gouider E,Bahri O,Djebbi A,Sadraoui A,Hafsia A,Hafsia R.[Blood-transmitted viral infections among haemophiliacs in Tunisia].Transfus Clin Biol 2005;12:301 -305[PMID:16099190 DOI:10.1016/j.tracli.2005.07.001]
366 KocabaE,Aksaray N,Alhan E,Tanyeli A,Kksal F,Yarkin F.Hepatitis B and C virus infections in Turkish children with cancer.Eur J Epidemiol 1997;13:869-873[PMID:9476814DOI:10.1023/A:1007420725704]
367 Kebudi R,Ayan I,Yílmaz G,AkícíF,Grgün O,Badur S.Seroprevalence of hepatitis B,hepatitis C,and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey.Med Pediatr Oncol2000;34:102-105[PMID:10657869 DOI:10.1002/(SICI)1096-911 X(200002)34]
368 Sonmez M,Bektas O,Yilmaz M,Durmus A,Akdogan E,Topbas M,Erturk M,Ovali E,Omay SB.The relation of lymphoma and hepatitis B virus/hepatitis C virus infections in the region of East Black Sea,Turkey.Tumori 2007;93:536-539[PMID:18338485]
369 Ocak S,Duran N,Kaya H,Emir I.Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and nondiabetic on haemodialysis.Int J Clin Pract 2006;60:670-674[PMID:16805751 DOI:10.1111/j.1368-5031.2006.00738.x]
370 Gul U,KiliA,Sakizligil B,Aksaray S,Bilgili S,Demirel O,Erinckan C.Magnitude of sexually transmitted infections among female sex workers in Turkey.J Eur Acad Dermatol Venereol 2008;22:1123-1124[PMID:18194239 DOI:10.1111/j.1468-3083.2007.02548.x]
371 Kksal I,Biberolu K,Biberolu S,KoF,Ayma Y,Aker F,Kksal H.Hepatitis C virus antibodies among risk groups in Turkey.Infection 1991;19:228-229[PMID:1917033 DOI:10 .1007/BF01644950]
372 Selcuk H,Kanbay M,Korkmaz M,Gur G,Akcay A,Arslan H,Ozdemir N,Yilmaz U,Boyacioglu S.Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment.Dig Dis Sci 2006;51:1420-1425[PMID:16868830 DOI:10.1007/s10620-005-9025-9]
373 Yakaryilmaz F,Gurbuz OA,Guliter S,Mert A,Songur Y,Karakan T,Keles H.Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.Ren Fail 2006;28:729-735[PMID:17162434 DOI:10.1080/08860220600925602]
374 Bozdayi G,Rota S,Verdi H,Derici U,Sindel S,Bali M,Baay T.[The presence of hepatitis C virus(HCV)infection in hemodialysis patients and determination of HCV genotype distribution].Mikrobiyol Bul 2002;36:291-300[PMID:12838663]
375 Sit D,Kadiroglu AK,Kayabasi H,Yilmaz ME,Goral V.Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a university hospital in Turkey.Intervirology 2007;50:133-137[PMID:17191015 DOI:10.1159/000098239]
376 KocabaE,Aksaray N,Alhan E,Yarkin F,Kksal F,KilinY.Hepatitis B and C virus infections in Turkish children with haemophilia.Acta Paediatr 1997;86:1135-1137[PMID:9350900 DOI:10.1111/j.1651-2227.1997.tb14824.x]
377 El Shahat YI,Varma S,Bari MZ,Shah Nawaz M,Abdulrahman S,Pingle A.Hepatitis C virus infection among dialysis patients in United arab emirates.Saudi J Kidney Dis Transpl1995;6:157-162[PMID:18583857]
378 Trad O,Hayek M,Jumaa P,Trad D,Uduman S.Seroprevalence of hepatitis B,hepatitis C and HIV among multiply transfused thalassemic children treated at Tawam Hospital.Emirates Med J 2003;21:17-20
379 Shidrawi R,Ali Al-Huraibi M,Ahmad Al-Haimi M,Dayton R,Murray-Lyon IM.Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers.J Med Virol 2004;73:562 -565[PMID:15221900 DOI:10.1002/jmv.20126]
380 Watts DM,Constantine NT,Sheba MF,Kamal M,Callahan JD,Kilpatrick ME.Prevalence of HIV infection and AIDS in Egypt over four years of surveillance(1986-1990).J Trop Med Hyg 1993;96:113-117[PMID:8459484]
381 El-Shabrawi MH,Zein El Abedin MY,Omar N,Kamal NM,Elmakarem SA,Khattab S,El-Sayed HM,El-Hennawy A,Ali AS.Predictive accuracy of serum hyaluronic acid as a noninvasive marker of fibrosis in a cohort of multi-transfused Egyptian children withβ-thalassaemia major.Arab J Gastroenterol 2012;13:45-48[PMID:22980590 DOI:10.1016/j.ajg.2012.06.006]
382 Abdelwahab MS,El-Raziky MS,Kaddah NA,Abou-Elew HH.Prevalence of hepatitis C virus infection and human immunodeficiency virus in a cohort of Egyptian hemophiliac children.Ann Saudi Med 2012;32:200-202[PMID:22366833]
383 Marcelin AG,Grandadam M,Flandre P,Nicand E,Milliancourt C,Koeck JL,Philippon M,Teyssou R,Agut H,Dupin N,Calvez V.Kaposi’s sarcoma herpesvirus and HIV-1 seroprevalences in prostitutes in Djibouti.J Med Virol 2002;68:164 -167[PMID:12210403 DOI:10.1002/jmv.10184]
384 Mokhbat JE,Naman RE,Rahme FS,Farah AE,Zahar KL,Maalouf A.Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons.J Med Liban 1989;38:9-14[PMID:2519339]
385 Mujeeb SA,Hafeez A.Prevalence and pattern of HIV infection in Karachi.J Pak Med Assoc 1993;43:2-4[PMID:8474215]
386 Novelli VM,Mostafavipour H,Abulaban M,Ekteish F,Milder J,Azadeh B.High prevalence of human immunodeficiency virus infection in children with thalassemia exposed to blood imported from the United States.Pediatr Infect Dis J1987;6:765-766[PMID:3670941 DOI:10.1097/00006454-198708000-00019]
387 el-Hazmi MA,Ramia S.Frequencies of hepatitis B,delta and human immune deficiency virus markers in multitransfused Saudi patients with thalassaemia and sickle-cell disease.J Trop Med Hyg 1989;92:1-5[PMID:2918572]
388 Al Saran K,Sabry A,Hassan AH,Al Halawany Z.Evaluation of quality of care in a large Saudi Hemodialysis Center(Prince Salman Center for Kidney Diseases,Riyadh,KSA).Ren Fail 2011;33:555-561[PMID:21663385 DOI:10.3109/0886022x.2011.581402]